Scientists Uncover New Cardiovascular Benefits of Popular Weight Loss Drugs

Share this post:

Obese Man Using Semaglutide OzempicNew studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in cardiac risk biomarkers linked to lifestyle interventions. New research published in JACC, the flagship journal of the American College of Cardiology, and presented at the American Heart Association’s 2024 Scientific Sessions highlights that widely used anti-obesity […]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *